Laboratory Corp. of America Holdings  

(Public, NYSE:LH)   Watch this stock  
Find more results for LH
+0.52 (0.51%)
Real-time:   9:46AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 101.39 - 102.02
52 week 87.01 - 108.77
Open 101.64
Vol / Avg. 2,012.00/588,781.00
Mkt cap 8.62B
P/E 16.91
Div/yield     -
EPS 6.01
Shares 84.90M
Beta 0.66
Inst. own 98%
Oct 28, 2014
Q3 2014 Laboratory Corporation of America Holdings Earnings Release - 9:30AM EDT - Add to calendar
Oct 28, 2014
Q3 2014 Laboratory Corporation of America Holdings Earnings Call - 9:00AM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 9.34% 9.91%
Operating margin 16.27% 17.06%
EBITD margin - 21.40%
Return on average assets 8.04% 8.36%
Return on average equity 21.98% 22.03%
Employees 34,000 -
CDP Score - -


BURLINGTON, NC 27215-5837
United States - Map
+1-336-2291127 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.

Officers and directors

David P. King Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Glenn A. Eisenberg Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
James T. Boyle Jr. Chief Operating Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Lance V. Berberian Senior Vice President, Chief Information Officer
Age: 52
Bio & Compensation  - Reuters
F Samuel Eberts III Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
Age: 54
Bio & Compensation  - Reuters
Mark Elliott Brecher M.D. Senior Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters
Robert E. Mittelstaedt Jr. Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
D. Gary Gilliland M.D., Ph.D. Director
Age: 59
Bio & Compensation  - Reuters
Garheng Kong M.D. Ph.D. Director
Age: 38
Bio & Compensation  - Reuters
Kerrii B. Anderson Independent Director
Age: 57
Bio & Compensation  - Reuters